F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

A Food and Drug Administration advisory committee voted to endorse broader use of peptides in compounding pharmacies, which operate under less stringent regulatory oversight than traditional pharmaceutical manufacturers. Compounding pharmacies have expanded into a multibillion-dollar business in recent years. The vote allows these pharmacies to produce peptide medications for wider patient populations.

Next story